102 related articles for article (PubMed ID: 5398117)
1. Influence of triperidol on the urinary elimination of bufotenin in schizophrenia.
Acebal EM
Behav Neuropsychiatry; 1969 Aug; 1(5):31. PubMed ID: 5398117
[No Abstract] [Full Text] [Related]
2. Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
Acebal EM; Spatz H
Int J Neuropsychiatry; 1967 Dec; 3(6):472-6. PubMed ID: 5583441
[No Abstract] [Full Text] [Related]
3. [Urinary excretion of catecholamines and 3-methoxy-4 hydroxy-mandelic acid in chronic schizophrenic patients undergoing Triperidol treatment].
Masiak M; Zawiślak H
Psychiatr Pol; 1973; 7(6):637-43. PubMed ID: 4773051
[No Abstract] [Full Text] [Related]
4. Studies on urinary elimination of bufotenine-like substances in schizophrenia.
Fischer E; Spatz H
Biol Psychiatry; 1970 Jul; 2(3):235-40. PubMed ID: 5505528
[No Abstract] [Full Text] [Related]
5. Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
Huszka L; Zabek DH; Doust JW
Can Psychiatr Assoc J; 1976 Dec; 21(8):541-6. PubMed ID: 1071579
[No Abstract] [Full Text] [Related]
6. Laboratory and animal studies on the chemistry of bufotenin. Quantitative determination on bufotenin in human urine.
Spatz H; Sireix DW; Marini FA; Fischer E; Bonhour A; Acebal EM
Behav Neuropsychiatry; 1969 Aug; 1(5):25-7. PubMed ID: 5398113
[No Abstract] [Full Text] [Related]
7. [Therapeutic effect of triperidol].
Cwynar S; Pionkowski J; Tomczak W; Tyszka E
Psychiatr Pol; 1968; 2(6):627-32. PubMed ID: 5730286
[No Abstract] [Full Text] [Related]
8. [Treatment of schizophrenic patients with triperidol (trisedil)].
Ezhkov AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1394-400. PubMed ID: 5705722
[No Abstract] [Full Text] [Related]
9. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
[No Abstract] [Full Text] [Related]
10. [Comparison of the therapeutic effect of triperidol with perphenazine in schizophrenia].
Náhunek K; Hádlik J; Svestka J; Rodová A; Vanýsek J
Cesk Psychiatr; 1969 Oct; 65(5):281-9. PubMed ID: 5363280
[No Abstract] [Full Text] [Related]
11. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
[No Abstract] [Full Text] [Related]
12. [On the position of butyrophenone derivative Triperidol in psychiatric treatment].
Lange E; Scholz V
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875
[No Abstract] [Full Text] [Related]
13. [Clinical trial of Triperidol drop preparation in psychotic patients with severe autistic, abulic and refusing attitude resisting life-guidance or occupational therapy].
Shimizu H; Sugimoto N
Iryo; 1970 Jul; 24(7):547-55. PubMed ID: 5458294
[No Abstract] [Full Text] [Related]
14. [Relationship between the effect of phenothiazine and butyrophenone and the glutamine level in the blood of schizophrenics].
Kluge H; Wieczorek V; Greger J; Hemke G; Hankowitz M
Wien Z Nervenheilkd Grenzgeb; 1968; 26(2):191-5. PubMed ID: 4239986
[No Abstract] [Full Text] [Related]
15. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia].
Weiser G
Wien Med Wochenschr; 1968 May; 118(19):444-6. PubMed ID: 5702494
[No Abstract] [Full Text] [Related]
16. Recent investigations of a possible dysmetabolic-endotoxic origin of schizophrenia.
Fischer E
Behav Neuropsychiatry; 1969 Aug; 1(5):27-9. PubMed ID: 5398114
[No Abstract] [Full Text] [Related]
17. [Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
Gauthier R; Hillel J; Bordeleau JM; Tétreault L
Union Med Can; 1967 Aug; 96(8):936-43. PubMed ID: 5618135
[No Abstract] [Full Text] [Related]
18. Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
Life Sci; 1967 Aug; 6(16):1697-706. PubMed ID: 6057885
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of a neuroleptic agent of the butyrophenone series: triperidol].
Gross H; Kaltenbäck E
Wien Med Wochenschr; 1966 Nov; 116(47):998-1001. PubMed ID: 5996763
[No Abstract] [Full Text] [Related]
20. [Presence of N-methylated and N-acetylated indolamines in urine from patients with schizophrenia and from normal individuals].
Faurbye A; Pind K
Ugeskr Laeger; 1971 Jul; 133(28):1356-8. PubMed ID: 5566986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
